EnBiotix is a late clinical-stage rare disease company currently focused on therapies for cystic fibrosis, non-CF bronchiectasis, and non-tuberculosis mycobacterial infections, a $15 billion global market. 

Pharmaceutical

EnBiotix

EnBiotix's headquarters in Boston, MA, United States

Jeffrey Wager

Stephan Wehselau

Juergen Froehlich

The leadership team at EnBiotix has experience in business development, finance, and research. They have a history of working with startups and new ventures. They also have experience in the biotech industry. They hold degrees in biomedical engineering and physics.

EnBiotix

Org chart

Teams

Leadership Team

Offices

EnBiotix

Org chart

Teams

Leadership Team

Offices

Related companies